← Leaderboards
Paul T Kotzbauer
University Of Pennsylvania
$14,878,940
Attributed
$17,699,960
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,699,960 · 10
By mechanism
R01$4,976,790 · 1
RF1$4,231,530 · 1
U01$4,058,563 · 1
U19$1,889,002 · 2
R21$1,270,500 · 3
K08$877,624 · 1
Top collaborators
- Chad M Rienstra1 shared
- Elizabeth R Wright1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Richard Assoian$21,573,073
- Meenhard Herlyn$50,214,821
- Joshua L Dunaief$17,622,335
- Eleonora Scorletti$180,929
- Edward J Delikatny$8,977,180
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsParkinson DiseaseNeuronsAlpha SynucleinPathologicBrain TissueLewy BodiesAutopsyImpairmentDepositionAmyloid Beta-ProteinAbeta AccumulationTissuesSamplingStructureDisease ProgressionDementiaBrain RegionAlzheimer&AposTau ProteinsBrainParkinson&AposIn VitroNovel Strategies
Grant awards (31)
NAPS2 Biofluid Core$437,388
U19 · FY2025 · AG · contact PI
Commercial production of alpha-synuclein fibrils amplified from human postmortem brain tissue to expand the availability of a critical research tool for Parkinson's disease$395,951
R41 · FY2025 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$712,576
R01 · FY2024 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$147,725
R01 · FY2024 · NS · contact PI
Structural Biology of Alpha-Synuclein in Lewy Body Dementia$4,231,530
RF1 · FY2023 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$712,576
R01 · FY2023 · NS · contact PI
NAPS2 Biofluid Core$484,808
U19 · FY2023 · AG · contact PI
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy$236,250
R21 · FY2023 · NS · contact PI
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA$805,681
U01 · FY2022 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$742,741
R01 · FY2022 · NS · contact PI
NAPS2 Biofluid Core$489,501
U19 · FY2022 · AG · contact PI
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy$196,875
R21 · FY2022 · NS · contact PI
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA$805,681
U01 · FY2021 · NS · contact PI
NAPS2 Biofluid Core$477,305
U19 · FY2021 · AG · contact PI
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA$805,681
U01 · FY2020 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$506,507
R01 · FY2020 · NS · contact PI
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA$804,161
U01 · FY2019 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$511,540
R01 · FY2019 · NS · contact PI
IDENTIFICATION OF FLUORESCENT LIGANDS FOR ALPHA SYNUCLEIN FIBRILS$228,750
R21 · FY2019 · NS · contact PI
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA$837,359
U01 · FY2018 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$511,540
R01 · FY2018 · NS · contact PI
IDENTIFICATION OF FLUORESCENT LIGANDS FOR ALPHA SYNUCLEIN FIBRILS$190,625
R21 · FY2018 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$511,540
R01 · FY2017 · NS · contact PI
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease$620,045
R01 · FY2016 · NS · contact PI
THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS$190,000
R21 · FY2012 · NS · contact PI
THERAPEUTIC APPROACHES FOR NEURODEGENERATION CAUSED BY PLA2G6 MUTATIONS$228,000
R21 · FY2011 · NS · contact PI
Neurodegenerative consequences of PanK2 mutations$176,002
K08 · FY2008 · NS · contact PI
Neurodegenerative consequences of PanK2 mutations$176,002
K08 · FY2007 · NS · contact PI
Neurodegenerative consequences of PanK2 mutations$176,002
K08 · FY2006 · NS · contact PI
Neurodegenerative consequences of PanK2 mutations$175,176
K08 · FY2005 · NS
Neurodegenerative consequences of PanK2 mutations$174,442
K08 · FY2004 · NS